End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.85 CNY | -0.20% | +2.64% | +45.24% |
13/05 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
25/04 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.24% | 1.93B | |
+41.50% | 6.2B | |
-22.89% | 4.1B | |
+9.36% | 3.41B | |
-19.39% | 2.83B | |
-11.05% | 2.29B | |
-7.51% | 1.52B | |
+46.81% | 1.51B | |
-18.04% | 1.49B | |
-19.10% | 1.42B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug